US 12,440,301 B2
System for delivery of a fiducial marker
Jacqueline Nerney Welch, Moraga, CA (US); Floria Cheng, San Francisco, CA (US); Jolene Cutts, San Francisco, CA (US); Alexander Charles Gordon, San Carlos, CA (US); Kevin Alexander Lessard, San Francisco, CA (US); Curtis Yarra, Oakland, CA (US); Christopher Zaler, Los Gatos, CA (US); and Joseph Catanese, III, San Leandro, CA (US)
Assigned to Teleflex Life Sciences LLC, Wilmington, DE (US)
Appl. No. 17/283,497
Filed by Teleflex Life Sciences LLC, Wilmington, DE (US)
PCT Filed Oct. 30, 2019, PCT No. PCT/US2019/058708
§ 371(c)(1), (2) Date Apr. 7, 2021,
PCT Pub. No. WO2020/096827, PCT Pub. Date May 14, 2020.
Prior Publication US 2021/0378784 A1, Dec. 9, 2021
Int. Cl. A61B 90/00 (2016.01); A61B 17/00 (2006.01); A61B 17/04 (2006.01)
CPC A61B 90/39 (2016.02) [A61B 17/00234 (2013.01); A61B 2017/00004 (2013.01); A61B 2017/00274 (2013.01); A61B 2017/0419 (2013.01); A61B 2017/0464 (2013.01); A61B 2090/3908 (2016.02); A61B 2090/3966 (2016.02); A61B 2090/3987 (2016.02)] 19 Claims
OG exemplary drawing
 
1. A system for delivering and depositing at least one fiducial marker to tissue at an interventional site within a body of a human patient, comprising:
an anchor assembly deployable at the interventional site, the anchor assembly comprising a first anchoring component, a second anchoring component, a connector, and the at least one fiducial marker, wherein:
the at least one fiducial marker comprises a sheet of a radiopaque material that forms an interference fit between at least one of the first anchoring component or the second anchoring component and the connector; and
a fiducial delivery device carrying the anchor assembly, the fiducial delivery device comprising:
an elongate member to be inserted into the body of the human patient and advanced to the interventional site; and
an actuator usable to deploy the anchor assembly at the interventional site.